Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 63

Sort by

Sort Order Select

Journal Articles

Longitudinal single-cell profiling of the bone marrow heterogeneity identifies the T-cell niche supporting cancer persister cells in follicular lymphoma

Karin Tarte, Alicia Beyou, Simon Leonard, Joelle DULONG, Stephane Rodriguez, Noushin Mossadegh-Keller, Gabriel Brisou, Charles BROTTIER, Luc Xerri, Bertrand Nadel, Camille Laurent, Guillaume Cartron, Sandrine Roulland

Blood (2025) 146 (Supplement 1): 553.

https://doi.org/10.1182/blood-2025-553

Published: 2025

Journal Articles

Glofitamab for patients with Non–Large B-cell lymphoma refractory or relapsing after anti-CD19 CAR T-cell therapy: Final bicar study (LYSA) results.

Blood (2025) 146 (Supplement 1): 5923.

https://doi.org/10.1182/blood-2025-5923

Published: 2025

Journal Articles

Circulating CD161high CD8 T cells at leukapheresis are associated with reduced risk of progression at 12 months (PFS12) in large B-cell lymphoma treated by axicabtagene ciloleucel: Results from the Phase 2 alycante study (LYSA)

Mikael Roussel, Juliette Ferrant, Ilenia Camille Manbangui, Simon Le Gallou, Charles BROTTIER, Delphine Rossille, Joelle DULONG, Marie-Helene Delfau, Alexis Claudel, François Lemonnier, Roch Houot, Camille Laurent, Karin Tarte

Blood (2025) 146 (Supplement 1): 5332.

https://doi.org/10.1182/blood-2025-5332

Published: 2025

Journal Articles

Glofitamab is superior to non a-CD3xC20 treatments for patients with diffuse large B-cell lymphoma who are refractory or relapse immediately after anti-CD19 CAR T-cell therapy: Final results of the bicar study (LYSA) and indirect comparison with a synthetic control arm from the descart registry.

Blood (2025) 146 (Supplement 1): 1958.

https://doi.org/10.1182/blood-2025-1958

Published: 2025

Journal Articles

Follicular Dendritic Cells Represent a Therapeutic Vulnerability in Early Follicular Lymphoma

Caitlin Gribbin, Dylan McNally, Ioannis Karagiannidis, Henna S. Nam, Hiranmayi Ravichandran, Baptiste Brauge, Karin Tarte, Amy Chadburn, Madhu M Ouseph, Sebastian Carrasco, Christian Steidl, David W. Scott, Ari M Melnick, Wendy Béguelin

Blood (2024) 144 (Supplement 1): 739.

https://doi.org/10.1182/blood-2024-198542

Published: 2024

Journal Articles

Carmod, an Open-Label, Multicenter, Proof of Concept, Phase II Trial, Investigating the Safety and Efficacy of Golcadomide in Post-CART for Patients with Relapsed/Refractory High-Risk Aggressive Large B-Cell Lymphoma

Catherine Thieblemont, François-Xavier Gros, Sandrine Roulland, Salim Kanoun, Veronique Meignin, Celine Row, Thierry Lamy, Emmanuel Gomez, Karin Tarte, Gabriel Brisou

Blood (2024) 144 (Supplement 1): 7226.

https://doi.org/10.1182/blood-2024-207843

Published: 2024

Journal Articles

Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm

Camille Laurent, Sascha Dietrich, Karin Tarte

Blood (2024) 143 (12): 1080–1090.

https://doi.org/10.1182/blood.2023021000

Published: 2024

Journal Articles

Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study

Blood (2023) 142 (Supplement 1): 893.

https://doi.org/10.1182/blood-2023-177703

Published: 2023

Journal Articles

Single-Cell Longitudinal Characterization of FL Heterogeneity and Residual Disease in the Bone Marrow from Low-Tumor Burden FL Enrolled in the Flirt Clinical Trial

Alicia Beyou, Simon Leonard, Ilenia Papa, Noushin Mossadegh-Keller, Sabrina Baaklini, Lionel Spinelli, Owen Hoare, Bertrand Nadel, Pierre Milpied, Joelle Dulong, Céline Monvoisin, Gabriel Brisou, Guillaume Cartron, Karin Tarte, Sandrine Roulland

Blood (2023) 142 (Supplement 1): 852.

https://doi.org/10.1182/blood-2023-186070

Published: 2023

Journal Articles

Periosteal Skeletal Stem Cells Can Migrate into the Bone Marrow and Support Hematopoietic Regeneration

Kemi Akinnola, Tony Marchand, Shoichiro Takeishi, Maria Marianovich, Sandra Pinho, Thierry Lamy, Karin Tarte, Julien Saint-Vanne, Paul S. Frenette, Kira Gritsman

Blood (2022) 140 (Supplement 1): 8629–8630.

https://doi.org/10.1182/blood-2022-169579

Published: 2022

Journal Articles

Sub-Cutaneous Administration of Rituximab Triggers a Pro-Phagocytic Phenotype of Monocytic Compartment in Low-Tumor Burden Follicular Lymphoma Patients Included in the Flirt Clinical Trial, a Lysa Study

Mikael Roussel, Cedric Menard, Delphine Rossille, Julien Saint-Vanne, Joelle Dulong, Emmanuel Bachy, Herve Tilly, Delphine Pranger, Franck Morschhauser, Luc Xerri, Guillaume Cartron, Karin Tarte

Blood (2022) 140 (Supplement 1): 6462–6463.

https://doi.org/10.1182/blood-2022-169295

Published: 2022

Journal Articles

PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma

Marion Haas, Gersende Caron, Fabrice Chatonnet, Stéphane Manenti, Elina Alaterre, Julie Devin, Céline Delaloy, Giulia Bertolin, Roselyne Viel, Amandine Pignarre, Francisco Llamas-Gutierrez, Anne Marchalot, Olivier Decaux, Karin Tarte, Laurent Delpy, Jérôme Moreaux, Thierry Fest

Blood (2022) 139 (15): 2316–2337.

https://doi.org/10.1182/blood.2021014011

Published: 2022

Includes: Supplemental data

Journal Articles

Extracellular vesicles shed by follicular lymphoma B cells promote polarization of the bone marrow stromal cell niche

Erwan Dumontet, Céline Pangault, David Roulois, Matthis Desoteux, Simon Léonard, Tony Marchand, Maelle Latour, Patricia Legoix, Damarys Loew, Florent Dingli, Joelle Dulong, Erwan Flecher, Cédric Coulouarn, Guillaume Cartron, Thierry Fest, Karin Tarte

Blood (2021) 138 (1): 57–70.

https://doi.org/10.1182/blood.2020008791

Published: 2021

Includes: Supplemental data

Journal Articles

Lenalidomide Enhance CAR T-Cells Response in Patients with Refractory/Relapsed Large B Cell Lymphoma Experiencing Progression after Infusion

Catherine Thieblemont, MD PhD, Sylvie Chevret, MD PhD, Vincent Allain, Roberta Di Blasi, Florence Morin, Laetitia Vercellino, Sandrine Roulland, PhD, Karin Tarte, PhDPharmD, Veronique Meignin, Sophie Caillat-Zucman, MD PhD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-136279

Published: 2020

Journal Articles

Niveau, a Phase 3 Study for Pts with B- or T-Cell Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivo lumab in Combination with G e mcitabine, Ox a liplatin (GemOx), Plus Rit u ximab (R) in Case of B-Cell Lymphoma

Blood (2019) 134 (Supplement_1): 5311.

https://doi.org/10.1182/blood-2019-129362

Published: 2019

Journal Articles

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

Thierry Fest, Fabienne Desmots-Loyer, Mikael Roussel, MD PhD, Celine Pangault, PhD, Cedric Pastoret, MD, Francisco Llamas-Gutierrez, Eric Guiheneuf, Valérie Camara-clayette, Thierry Lamy, Pr, MD PhD, Karin Tarte, PhD, Vincent Ribrag, MD

Blood (2018) 132 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2018-99-113269

Published: 2018

Journal Articles

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

Franck Morschhauser, Gilles Salles, Steven Le Gouill, Herve Tilly, Catherine Thieblemont, Krimo Bouabdallah, Bettina Fabiani, Cédric Ménard, Karin Tarte, Guillaume Cartron, Roch Houot

Blood (2018) 132 (14): 1486–1494.

https://doi.org/10.1182/blood-2018-05-853499

Published: 2018

Journal Articles

Lenalidomide Treatment Restores In Vivo T Cell Activity in Relapsed/Refractory FL and DLBCL

Cedric Menard, Joelle Dulong, Tien Tuan Nguyen, MD PhD, Nadège Bescher, Maelle Latour, Isabelle Bézier, Séverine Loisel, PhD, Roch Houot, Pr, MD PhD, Thierry Lamy, Pr, MD PhD, Franck Morschhauser, MD PhD, Karin Tarte, Pr, PhD

Blood (2017) 130 (Supplement 1): 729.

https://doi.org/10.1182/blood.V130.Suppl_1.729.729

Published: 2017

Journal Articles

Follicular Lymphoma Regulatory T Cell Function and Origin

Karin Tarte, Pr, PhD, Stephane Rodriguez, PhD, Patricia Ame-Thomas, PhD, Alexis Saintamand, PhD, Mehdi Alizadeh, PhD, Celine Monvoisin, Inaki Martin Subero, PhD, Thierry Lamy, Pr, MD PhD

Blood (2017) 130 (Supplement 1): 2762.

https://doi.org/10.1182/blood.V130.Suppl_1.2762.2762

Published: 2017

Journal Articles

IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma

Shubham Pandey, Frédéric Mourcin, Tony Marchand, Saba Nayar, Marion Guirriec, Céline Pangault, Céline Monvoisin, Patricia Amé-Thomas, Fabien Guilloton, Joelle Dulong, Mark Coles, Thierry Fest, Anja Mottok, Francesca Barone, Karin Tarte

Blood (2017) 129 (18): 2507–2518.

https://doi.org/10.1182/blood-2016-08-737239

Published: 2017

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Longitudinal single-cell profiling of the bone marrow heterogeneity identifies the T-cell niche supporting cancer persister cells in follicular lymphoma

Glofitamab for patients with Non–Large B-cell lymphoma refractory or relapsing after anti-CD19 CAR T-cell therapy: Final bicar study (LYSA) results.

Circulating CD161high CD8 T cells at leukapheresis are associated with reduced risk of progression at 12 months (PFS12) in large B-cell lymphoma treated by axicabtagene ciloleucel: Results from the Phase 2 alycante study (LYSA)

Glofitamab is superior to non a-CD3xC20 treatments for patients with diffuse large B-cell lymphoma who are refractory or relapse immediately after anti-CD19 CAR T-cell therapy: Final results of the bicar study (LYSA) and indirect comparison with a synthetic control arm from the descart registry.

Follicular Dendritic Cells Represent a Therapeutic Vulnerability in Early Follicular Lymphoma

Carmod, an Open-Label, Multicenter, Proof of Concept, Phase II Trial, Investigating the Safety and Efficacy of Golcadomide in Post-CART for Patients with Relapsed/Refractory High-Risk Aggressive Large B-Cell Lymphoma

Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm

Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study

Single-Cell Longitudinal Characterization of FL Heterogeneity and Residual Disease in the Bone Marrow from Low-Tumor Burden FL Enrolled in the Flirt Clinical Trial

Periosteal Skeletal Stem Cells Can Migrate into the Bone Marrow and Support Hematopoietic Regeneration

Sub-Cutaneous Administration of Rituximab Triggers a Pro-Phagocytic Phenotype of Monocytic Compartment in Low-Tumor Burden Follicular Lymphoma Patients Included in the Flirt Clinical Trial, a Lysa Study

PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma

Extracellular vesicles shed by follicular lymphoma B cells promote polarization of the bone marrow stromal cell niche

Lenalidomide Enhance CAR T-Cells Response in Patients with Refractory/Relapsed Large B Cell Lymphoma Experiencing Progression after Infusion

Niveau, a Phase 3 Study for Pts with B- or T-Cell Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivo lumab in Combination with G e mcitabine, Ox a liplatin (GemOx), Plus Rit u ximab (R) in Case of B-Cell Lymphoma

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

Lenalidomide Treatment Restores In Vivo T Cell Activity in Relapsed/Refractory FL and DLBCL

Follicular Lymphoma Regulatory T Cell Function and Origin

IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only